<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology of community-acquired bacterial meningitis in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology of community-acquired bacterial meningitis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology of community-acquired bacterial meningitis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rodrigo Hasbun, MD, MPH, FIDSA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allan R Tunkel, MD, PhD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Mitty, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 26, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In the pre-antibiotic era, bacterial meningitis due to <em>Streptococcus pneumoniae</em> and <em>Haemophilus influenzae</em> was virtually 100 percent fatal. With the advent of antibiotics, the mortality for <em>H. influenzae</em> and <em>Neisseria meningitidis </em>infections decreased to &lt;10 percent, and that of <em>S. pneumoniae</em> to 30 percent [<a href="#rid1">1</a>]. Mortality due to <em>S. pneumoniae</em> meningitis in high-income countries has further decreased with the use of adjunctive steroids [<a href="#rid2">2</a>]. Meningitis remains an important global health disease despite the effectiveness of current antibiotics as well as the availability of conjugate vaccines for the three most common meningeal pathogens [<a href="#rid3">3,4</a>]. </p><p>The epidemiology of community-acquired bacterial meningitis in adults will be reviewed here. The pathogenesis, clinical features, treatment, prognosis, and prevention of bacterial meningitis in adults and children and issues related to chronic and recurrent meningitis are discussed separately. (See  <a class="medical medical_review" href="/d/html/1289.html" rel="external">"Pathogenesis and pathophysiology of bacterial meningitis"</a> and  <a class="medical medical_review" href="/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults"</a> and  <a class="medical medical_review" href="/d/html/5968.html" rel="external">"Bacterial meningitis in children older than one month: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6010.html" rel="external">"Bacterial meningitis in children older than one month: Treatment and prognosis"</a> and  <a class="medical medical_review" href="/d/html/1275.html" rel="external">"Approach to the patient with chronic meningitis"</a> and  <a class="medical medical_review" href="/d/html/3908.html" rel="external">"Approach to the adult with recurrent infections", section on 'Meningitis'</a>.)</p><p>The epidemiology of health care-associated meningitis and ventriculitis is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1302.html" rel="external">"Health care-associated meningitis and ventriculitis in adults: Clinical features and diagnosis", section on 'Incidence and risk factors'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE</span></p><p class="headingAnchor" id="H2242131494"><span class="h2">United States</span><span class="headingEndMark"> — </span><em>S. pneumoniae </em>and <em>N. meningitidis </em>are the two major organisms causing community-acquired meningitis (<a class="graphic graphic_table graphicRef73706" href="/d/graphic/73706.html" rel="external">table 1</a>) [<a href="#rid5">5-7</a>]. The high frequency of pneumococcal meningitis in adults reflects the relatively high rate of pneumococcal infection in the community. </p><p>In the United States and other countries, following the institution of routine infant immunization with the conjugate <em>H. influenzae</em> type b vaccine in 1990 and the 7-valent <em>S. pneumoniae</em> (pneumococcus) conjugate vaccine in 2000, followed by the 13-valent pneumococcal vaccine (<a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">PCV13</a>) in 2010, bacterial meningitis decreased in frequency, and the peak incidence of bacterial meningitis has shifted from children under five years of age to adults (<a class="graphic graphic_figure graphicRef98806" href="/d/graphic/98806.html" rel="external">figure 1</a>) [<a href="#rid5">5,8,9</a>]. The frequency with which various bacteria cause meningitis in children is discussed separately [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/d/html/5968.html" rel="external">"Bacterial meningitis in children older than one month: Clinical features and diagnosis", section on 'Epidemiology'</a>.) </p><p>It has been estimated that meningitis occurs in only 4 percent of invasive pneumococcal infections, compared with 48 percent of invasive <em>N. meningitidis</em> infections, 30 percent of invasive listeriosis, 10 percent of invasive <em>H. influenzae</em> infections, and 4 percent of invasive group B streptococcal infections [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/7013.html" rel="external">"Pneumococcal pneumonia in patients requiring hospitalization"</a> and  <a class="medical medical_review" href="/d/html/1300.html" rel="external">"Clinical manifestations of meningococcal infection"</a> and  <a class="medical medical_review" href="/d/html/1277.html" rel="external">"Clinical manifestations and diagnosis of Listeria monocytogenes infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>S. pneumoniae </em></strong>–<strong> </strong>In a population-based observational study between 1997 and 2010 in the United States, the most common identifiable pathogen was <em>S. pneumoniae </em>(21,858 cases) with an incidence of 0.306 cases per 100,000 people [<a href="#rid6">6</a>]. With the introduction of the <a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">PCV13</a> in 2010, the number of cases in the United States remained unchanged, although the proportion of cases caused by serotypes in the vaccine decreased significantly [<a href="#rid11">11</a>]. A subsequent 16-year prospective study in France showed a reduction in the incidence of pneumococcal meningitis in children after the implementation of PCV13, but with a sharp increase in cases in the last two years of the study due to serotype 24F, which is not present in the current vaccine [<a href="#rid12">12</a>]. The impact of PCV on invasive pneumococcal disease in adults is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults", section on 'Rationale for vaccination'</a> and  <a class="medical medical_review" href="/d/html/3168.html" rel="external">"Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia in adults", section on 'Epidemiology'</a>.) </p><p></p><p class="bulletIndent1">Another important trend has been the increase in incidence of penicillin-resistant S. pneumoniae meningitis worldwide. This is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/7034.html" rel="external">"Resistance of <i>Streptococcus pneumoniae</i> to beta-lactam antibiotics"</a> and  <a class="medical medical_review" href="/d/html/7023.html" rel="external">"<i>Streptococcus pneumoniae</i>: Microbiology and pathogenesis of infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>N. meningitidis </em></strong>– The incidence of<em> Neisseria meningitidis </em>infection has decreased likely associated with meningococcal vaccination in the United States and now occurs at rates close to common bacterial causes of nosocomial meningitis such as staphylococcus, gram-negative bacteria, and<em> H. influenzae</em> [<a href="#rid6">6</a>]. In 2018, the incidence of meningococcal disease was 0.10 per 100,000 persons [<a href="#rid7">7</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>H. influenzae</em></strong><strong> type b </strong>– In a population-based observational study in the United States (1997 to 2010), the incidence of <em>H. influenzae</em> meningitis decreased from 0.10 to 0.058 per 100,000 people [<a href="#rid6">6</a>]. A more recent study of 694 infants with meningitis admitted to a large pediatric hospital between 2010 and 2017 found only one case of <em>H. influenzae</em> [<a href="#rid13">13</a>]. This marked decrease is presumed due to widespread vaccination of infants. Strains other than type b continue to cause occasional invasive infection (including meningitis) in children and adults. In an epidemiologic study of <em>H. influenzae</em> disease in children, an increase of invasive <em>H. influenzae</em> disease was noted and mainly caused by nontypeable and type a strains [<a href="#rid14">14</a>]</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Global</span><span class="headingEndMark"> — </span><em>S. pneumoniae</em> remains the most common etiology globally, accounting for approximately 25 to 41 percent of cases [<a href="#rid4">4</a>]. In a prospective review of 1412 episodes of community-acquired bacterial meningitis in the Netherlands from 2006 to 2014, <em>S. pneumoniae</em> was responsible for 51 percent, <em>N. meningitidis</em> for 37 percent, and <em>L. monocytogenes</em> for 4 percent of cases [<a href="#rid9">9</a>]. The remaining cases were primarily due to <em>H. influenzae</em>, streptococci, <em>Staphylococcus aureus</em>, and gram-negative bacilli.</p><p>The distribution of pathogens depends upon the region of the world. As an example, large epidemics of meningitis due to <em>N. meningitidis</em> serogroup A used to occur in sub-Saharan Africa. Although the implementation of the meningococcal group A conjugate vaccine has virtually eliminated meningococcal group A, epidemics due to non-group A meningococcal and other meningeal pathogens continue to occur [<a href="#rid15">15</a>]. In Ghana, pneumococcal meningitis is still common despite introduction of <a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">PCV13</a> into the routine infant immunization program, predominantly due to meningitis caused by serotype 1 [<a href="#rid16">16</a>]. </p><p><em>Streptococcus suis </em>is an emerging zoonosis that causes meningitis in Asia and has been linked to exposure to pigs [<a href="#rid17">17</a>]. It is the most frequent cause of bacterial meningitis in adults in southern Vietnam and has caused outbreaks in China. </p><p class="headingAnchor" id="H2274127701"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>In community-acquired meningitis, the organism responsible for acute bacterial meningitis depends in part upon the route of acquisition and underlying host factors (<a class="graphic graphic_table graphicRef73706" href="/d/graphic/73706.html" rel="external">table 1</a>). There are three major mechanisms for developing meningitis:</p><p class="bulletIndent1"><span class="glyph">●</span>Colonization of the nasopharynx, with subsequent bloodstream invasion followed by central nervous system (CNS) invasion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Invasion of the CNS following bacteremia due to a localized source, such as infective endocarditis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Direct entry of organisms into the CNS from a contiguous infection (eg, sinuses, mastoid), trauma, or a cerebrospinal fluid (CSF) leak [<a href="#rid18">18</a>].</p><p></p><p>Risk factors for recurrent bacterial meningitis are similar to risk factors for initial episodes and include anatomic defects of the spinal cord, brain or inner ear, acquired defects due basilar skull fractures or surgery, parameningeal infections, or immunodeficiency [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/3908.html" rel="external">"Approach to the adult with recurrent infections", section on 'Meningitis'</a>.)</p><p>Host factors that can predispose to meningitis include asplenia, complement deficiency, glucocorticoid excess, diabetes mellitus, alcoholism, hypogammaglobulinemia, and HIV infection (<a class="graphic graphic_table graphicRef72293" href="/d/graphic/72293.html" rel="external">table 2</a>). Patients with suspected meningitis should also be questioned for other predisposing factors, such as:</p><p class="bulletIndent1"><span class="glyph">●</span>Recent infection (especially respiratory or ear infection)</p><p class="bulletIndent1"><span class="glyph">●</span>Recent exposure to someone with meningitis</p><p class="bulletIndent1"><span class="glyph">●</span>Injection drug use</p><p class="bulletIndent1"><span class="glyph">●</span>Recent head trauma</p><p class="bulletIndent1"><span class="glyph">●</span>Otorrhea or rhinorrhea</p><p class="bulletIndent1"><span class="glyph">●</span>Recent travel (eg, Hajj pilgrimage) [<a href="#rid20">20</a>]</p><p></p><p>The frequency of underlying host risk factors in patients with bacterial meningitis was illustrated in a series of 1412 patients in the Netherlands [<a href="#rid9">9</a>]. Almost one-half had a predisposing condition such as otitis or sinusitis (34 percent), pneumonia (9 percent), or an immunocompromised state (11 percent).</p><p class="headingAnchor" id="H1938388"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16956.html" rel="external">"Patient education: Bacterial meningitis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H14126489"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>In the pre-antibiotic era bacterial meningitis was virtually 100 percent fatal. Despite the effectiveness of current antibiotics in clearing bacteria from the cerebrospinal fluid (CSF), bacterial meningitis continues to cause significant morbidity and mortality worldwide. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the United States, following the institution of routine infant immunization with the conjugate <em>Haemophilus influenzae</em> type b vaccine in 1990 and the 7-valent <em>Streptococcus pneumoniae</em> (pneumococcus) conjugate vaccine in 2000 (PCV7) followed by the 13-valent pneumococcal vaccine (<a class="drug drug_general" data-topicid="9906" href="/d/drug information/9906.html" rel="external">PCV13</a>) in 2010, bacterial meningitis has decreased in frequency, and the peak incidence of bacterial meningitis has shifted from children under five years of age to adults (<a class="graphic graphic_figure graphicRef98806" href="/d/graphic/98806.html" rel="external">figure 1</a>). (See <a class="local">'Incidence'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>S. pneumoniae rem</em>ains the leading pathogen of community-acquired bacterial meningitis globally and continues to be associated with a high mortality rate. (See <a class="local">'Global'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Large epidemics of meningitis due to serogroup A <em>Neisseria meningitidis </em>in sub-Saharan Africa have been eliminated by mass vaccination using the meningococcal A conjugate vaccine, but epidemics due to non-group A meningococcal and other meningeal pathogens continue to occur. (See <a class="local">'Global'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Streptococcus suis</em> is an emerging zoonosis that causes meningitis in Asia and has been linked to exposure to pigs or pork. (See <a class="local">'Global'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Despite the decreased mortality of meningitis with the advent of effective antibiotics, mortality from meningitis still remains significant. The use of adjunctive <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> in pneumococcal meningitis has been shown in clinical trials and observational studies to decrease mortality in high-income countries. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The organism responsible for acute bacterial meningitis depends in part upon the route of acquisition and underlying host factors (<a class="graphic graphic_table graphicRef73706" href="/d/graphic/73706.html" rel="external">table 1</a>). There are three major mechanisms for developing meningitis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Colonization of the nasopharynx, with subsequent bloodstream invasion followed by central nervous system (CNS) invasion</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Invasion of the CNS following bacteremia due to a localized source, such as infective endocarditis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct entry of organisms into the CNS from a contiguous infection (eg, sinuses, mastoid), trauma, or a CSF leak (see <a class="local">'Risk factors'</a> above)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Swartz MN. Bacterial meningitis--a view of the past 90 years. N Engl J Med 2004; 351:1826.</a></li><li><a class="nounderline abstract_t">Brouwer MC, Heckenberg SG, de Gans J, et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010; 75:1533.</a></li><li><a class="nounderline abstract_t">van de Beek D, Brouwer M, Hasbun R, et al. Community-acquired bacterial meningitis. Nat Rev Dis Primers 2016; 2:16074.</a></li><li><a class="nounderline abstract_t">Oordt-Speets AM, Bolijn R, van Hoorn RC, et al. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLoS One 2018; 13:e0198772.</a></li><li><a class="nounderline abstract_t">Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011; 364:2016.</a></li><li><a class="nounderline abstract_t">Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis 2014; 14:813.</a></li><li class="breakAll">Meningococcal disease surveillance CDC https://www.cdc.gov/meningococcal/surveillance/index.html (Accessed on December 16, 2019).</li><li><a class="nounderline abstract_t">Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008; 46:1664.</a></li><li><a class="nounderline abstract_t">Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 2016; 16:339.</a></li><li><a class="nounderline abstract_t">Bijlsma MW, Bekker V, Brouwer MC, et al. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. Lancet Infect Dis 2014; 14:805.</a></li><li><a class="nounderline abstract_t">Olarte L, Barson WJ, Barson RM, et al. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis 2015; 61:767.</a></li><li><a class="nounderline abstract_t">Ouldali N, Levy C, Varon E, et al. Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey. Lancet Infect Dis 2018; 18:983.</a></li><li><a class="nounderline abstract_t">Erickson TA, Munoz FM, Troisi CL, et al. The Epidemiology of Meningitis in Infants under 90 Days of Age in a Large Pediatric Hospital. Microorganisms 2021; 9.</a></li><li><a class="nounderline abstract_t">Vallejo JG, McNeil JC, Hultén KG, et al. Invasive Haemophilus influenzae Disease at Texas Children's Hospital, 2011 to 2018. Pediatr Infect Dis J 2019; 38:900.</a></li><li><a class="nounderline abstract_t">Trotter CL, Lingani C, Fernandez K, et al. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Lancet Infect Dis 2017; 17:867.</a></li><li><a class="nounderline abstract_t">Bozio CH, Abdul-Karim A, Abenyeri J, et al. Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine. PLoS One 2018; 13:e0203205.</a></li><li><a class="nounderline abstract_t">van Samkar A, Brouwer MC, Schultsz C, et al. Streptococcus suis Meningitis: A Systematic Review and Meta-analysis. PLoS Negl Trop Dis 2015; 9:e0004191.</a></li><li><a class="nounderline abstract_t">Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.</a></li><li><a class="nounderline abstract_t">Hasbun R. Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies. Expert Rev Anti Infect Ther 2021; 19:993.</a></li><li><a class="nounderline abstract_t">Yezli S. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review. Travel Med Infect Dis 2018; 24:51.</a></li></ol></div><div id="topicVersionRevision">Topic 1294 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15509815" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bacterial meningitis--a view of the past 90 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881273" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27808261" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Community-acquired bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29889859" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Global etiology of bacterial meningitis: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21612470" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bacterial meningitis in the United States, 1998-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104307" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104307" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18433334" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26652862" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104306" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25972022" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30049623" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33806478" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Epidemiology of Meningitis in Infants under 90 Days of Age in a Large Pediatric Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31107422" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Invasive Haemophilus influenzae Disease at Texas Children's Hospital, 2011 to 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28545721" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30192772" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26505485" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Streptococcus suis Meningitis: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416268" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute bacterial meningitis in adults. A review of 493 episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33334204" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29751133" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
